AgingResearch.NewsJoin free

Zydus Lifesciences

CompanyIndiaFounded 1952

RORWikidata

Zydus Lifesciences develops one asset, approved (riociguat in chronic thromboembolic pulmonary hypertension). Mostly small molecule acting on GUCY1A1 and GUCY1B1; based in India, founded in 1952.

1
Asset
Furthest stage
Approved
1
Trial
3
Signals

Pipeline

1

  • riociguat

    Soluble guanylate cyclase stimulator enhancing cGMP production to cause vasodilation.

    Approved, Small molecule, GUCY1A1, GUCY1B1, chronic thromboembolic pulmonary hypertension, pulmonary arterial hypertension

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Evidence behind the mechanisms2
  • Trials1
  • Signals3
  • Similar companies6

Papers

Intelligence